New Treatments for Fecal Incontinence: Update for the Gastroenterologist

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 11, 2014, Pages 1783-1788

  Wald, Arnold ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Injectable Anal Bulking Agents; Neuromodulation; Sacral Nerve Stimulation

Indexed keywords

BULKING AGENT; DEXTRANOMER; HYALURONIC ACID; DEXTRAN;

ANAL CANAL; ANORECTAL PRESSURE; ANUS SPHINCTER; ARTICLE; FECES INCONTINENCE; GASTROENTEROLOGIST; HEALTH CARE PERSONNEL; HUMAN; MOTOR PERFORMANCE; NEUROMODULATION; PATIENT CARE; PATIENT SATISFACTION; PUBLICATION; QUALITY OF LIFE; SACRAL NERVE STIMULATION; SELF CONCEPT; SHAM PROCEDURE; URGE INCONTINENCE; URINE INCONTINENCE; FECAL INCONTINENCE; INJECTION; PROCEDURES; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION;

DEXTRANS; FECAL INCONTINENCE; HUMANS; INJECTIONS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 84908247608     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.02.013     Document Type: Article

References (35)

1. Ditah I., Devaki P., Luma H.N., et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005-2010. Clin Gastroenterol Hepatol 2013 July 29, Epub ahead of print.
2. Nelson R.L. Epidemiology of fecal incontinence. Gastroenterology 2004, 126(Suppl 1):S3-S7.
3. Leigh R.J., Turnberg L.A. Faecal incontinence: the unvoiced symptom. Lancet 1982, 1:1349-1351.
4. Wald A. Clinical practice. Fecal incontinence in adults. NEngl J Med 2007, 356:1648-1655.
5. Wong R.K., Drossman D.A., Bharucha A.E., et al. The digital rectal exam: a multicenter survey of physician and students' perceptions and practice. Am J Gastroenterol 2012, 11:947-957.
6. Bharucha A.E., Zinsmeister A.R., Schleck C.D., et al. Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology 2010, 139:1559-1566.
7. Omar M.I., Alexander C.E. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2013, 6:CD00216.
8. Brown S.R., Wadhawan H., Nelson R.L. Surgery for faecal incontinence in adults. Cochrane Database Syst Rev 2013, 7:CD001757.
9. Halverson A.L., Hull T.L. Long-term outcome of overlapping anal sphincter repair. Dis Colon Rectum 2002, 45:345-348.
10. Lehto K., Hyöty M., Collin P., et al. Seven-year follow-up after anterior sphincter reconstruction for faecal incontinence. Int J Colorectal Dis 2013, 28:653-658.
11. Bravo Gutierrez A., Madoff R.D., Lowry A.C., et al. Long-term results of anterior sphincteroplasty. Dis Colon Rectum 2004, 47:727-731.
12. George A.T., Kalmar K., Sala S., et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg 2013, 100:330-338.
13. Maeda Y., Laurberg S., Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2013, 2:CD007959.
14. Graf W., Mellgren A., Matzel K.E., et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 2011, 377:997-1003. NASHA Dx Study Group.
15. Molitierno J.A., Scherz H.C., Kirsch A.J. Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. JPediatr Urol 2008, 4:221-228.
16. Bharucha A.E., Fletcher J.G., Harper C.M., et al. Relationship between symptoms and disordered continence mechanisms in women with fecal incontinence. Gut 2005, 54:546-555.
17. Jorge J.M., Wexner S.D. Etiology and management of fecal incontinence. Dis Colon Rectum 1993, 36:77-97.
18. Rockwood T.H., Church J.M., Fleshman J.W., et al. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000, 43:9-16.
19. Leighton J.A., Valdovinos M.A., Pemberton J.H., et al. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 1993, 36:182-185.
20. Kushwaha R.S., Hayne D., Vaizey C.J., et al. Physiologic changes of the anorectum after pelvic radiotherapy for the treatment of prostate and bladder cancer. Dis Colon Rectum 2003, 46:1182-1188.
21. Engel A.F., Kamm M.A., Bartram C.I., et al. Relationship of symptoms of faecal incontinence to specific sphincter abnormalities. Int J Colorect Dis 1995, 10:152-155.
22. Dehli T., Stordahl A., Vatten L.J., et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol 2013, 48:302-310.
23. Wald A. Clonidine and botulinum toxin: a tale of two treatments. Clin Gastroenterol Hepatol 2014, 12:852-853.
24. Whitehead W.E., Corazziari E., Prizont R., et al. Definition of a responder in clinical trials for functional gastrointestinal disorders: report on a symposium. Gut 1999, 45(Suppl 2):II78-II79.
25. Bharucha A.E., Zinsmeister A.R., Locke G.R., et al. Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol 2006, 4:1004-1009.
26. Tanagho E.A., Schmidt R.A. Electrical stimulation in the clinical management of the neurogenic bladder. JUrol 1988, 140:1331-1339.
27. Leroi A.M., Michot F., Grise P., et al. Effect of sacral nerve stimulation in patients with faecal and urinary incontinence. Dis Colon Rectum 2001, 44:779-789.
28. Wexner S.D., Coller J.A., Devroede G., et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg 2010, 251:441-449.
29. Tjandra J.J., Chan M.K., Yeh C.H., et al. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum 2008, 51:494-502.
30. Patton V., Wiklendt L., Arkwright J.W., et al. The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg 2013, 100:959-968.
31. de Miguel M., Oteiza F., Ciga M.A., et al. Sacral nerve stimulation for treatment of fecal incontinence following low anterior resection for rectal cancer. Colorectal Dis 2013, 13:72-77.
32. LaTorre F., de la Portilla F. Long- term efficacy of dextronomer in stabilized hyaluronic acid (NASHA Dx) for treatment of fecal incontinence. Colorectal Dis 2013, 15:569-574.
33. Heymen S., Scarlett Y., Jones K., et al. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercisesfor fecal incontinence. Dis Colon Rectum 2009, 52:1730-1737.
34. Wald A., Bharucha A.E., Rao S.S., et al. Functional disorders of the rectum and anus. Rome III-the functional gastrointestinal disorders 2006, 639-685. Degnon Associates, McLean, VA. 3rd ed. D. Drossman, E. Corazziari, N.J. Talley (Eds.).
35. Thin N.N., Horrocks E.J., Hotouras A., et al. Systematic review of the clinical effectiveness of neuromodulation in the treatment of fecal incontinence. Br J Surg 2013, 100:1430-1437.